[Edaily Starin Choi Hee-jae Reporter] Director Christopher Nolan’s film “The Martian” has surpassed $1.1 billion in global box office revenue. This marks the highest-grossing film in Christopher Nolan’s career. Poster for the movie “The Martian” (Photo: Universal Pictures) According to Box Office Mojo on the 11th, “The Martian” recorded global box office revenue of $1.10480489 billion (approximately 1.563 trillion won), demonstrating its overwhelming box office power. This surpasses the previous record held by Christopher Nolan’s “The Dark Knight Rises” ($1,085,429,532). “The Martian” has become the highest-grossing film in Nolan’s filmography globally, continuing his streak of setting new records. Its popularity in South Korea is also soaring. Since its release on the 5th, it has held the number one spot at the box office for six consecutive days, dominating the charts. Additionally, *The Martian* surpassed 2 million viewers on its sixth day of release. This is six days faster than *The Man Who Shared the King’s Life* (*Wangsa Nam*), which became a “10-million-viewer film” in South Korea with a total audience of 16.91 million. “The Odyssey” depicts the journey of Odysseus (played by Matt Damon), the hero who led the 10-year Trojan War to victory, as he sets out to return to his wife Penelope (played by Anne Hathaway) and his son Telemachus (played by Tom Holland). As the latest film from director Christopher Nolan—whose previous works, including *Interstellar*, *Dunkirk*, *Tenet*, and *Oppenheimer*, have drawn over 36 million viewers in South Korea alone—it has generated high anticipation. In particular, it garnered attention as the first film in cinematic history to be shot entirely with IMAX film cameras. The film stars Matt Damon, Tom Holland, Anne Hathaway, Robert Pattinson, Lupita Nyong’o, Zendaya Coleman, and Charlize Theron.
“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
#The BORN Korea announced on the 13th that it posted a consolidated operating loss of 3.7 billion won in the third quarter of this year. This represents an improvement in the loss compared to the same…
Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…